Factors Influencing Change in Serum Uric Acid after Administration of the Sodium-Glucose Cotransporter 2 Inhibitor Luseogliflozin in Patients With Type 2 Diabetes Mellitus
This article is protected by copyright. All rights reserved.PMID:34545949 | DOI:10.1002/jcph.1970
Source: The Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Authors: Yukihiro Chino Masanari Kuwabara Ichiro Hisatome Source Type: research
More News: Diabetes | Diabetes Mellitus | Diabetes Type 2 | Drugs & Pharmacology | Endocrinology | SGLT2 Inhibitors | Sodium | Study